Clinical Trials on Infections, Streptococcal

Total 56449 results

Sinovac Biotech Co., Ltd

Completed

A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine

Pneumococcal Infections

China
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of V114 in Healthy Adults (V114-019/PNEU-AGE) (PNEU-AGE)

Pneumococcal Infections

Taiwan, United States, Canada, Japan, Spain
Arto Palmu
GlaxoSmithKline

Completed

Indirect Effects of Pneumococcal Vaccine on Nasopharyngeal Carriage (FinIPcarr)

Pneumococcal Infections

Finland
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

Pneumococcal Infections

Korea, Republic of
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Adults 60 Through 64 Years of Age

Pneumococcal Infections

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)

Pneumococcal Infections
Pfizer

Completed

A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years

Pneumococcal Infections

United States
Agence de Médecine Préventive, France

Completed

Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina Faso (PCV13-Bobo)

Pneumococcal Infections

Burkina Faso
Pfizer

Completed

13-valent Pneumococcal Conjugate Vaccine Study in Adults => 50 Years of Age in Mexico

Pneumococcal Infections

Mexico
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Investigating Administration of Prevenar for Post-Marketing Surveillance

Pneumococcal Infections

Korea, Republic of
Centers for Disease Control and Prevention
Southcentral Foundation; Alaska Native Tribal Health Consortium

Completed

Immunogenicity and Reactogenicity of Pneumococcal Polysaccharide and Conjugate Vaccines in Native Elders

Pneumococcal Infections

United States
Fondation Hôpital Saint-Joseph

Completed

Characterization of Enterococcus Faecalis Endocarditis and Impact of Amoxicillin MIC Elevation on Patient Outcome (ENDO_ENTERO)

Infectious Endocarditis

France
Quidel Corporation

Completed

Strep A FIA Field Study, Sofia

Group A Streptococcus

United States
UNION therapeutics

Completed

Study Evaluating the Safety, Tolerability, PK, and Activity of Topical ATx201 Gel in Outpatients With Impetigo

Impetigo

South Africa
Ferrer Internacional S.A.

Completed

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Impetigo

Germany, South Africa
LEO Pharma

Terminated

Fucidin® Cream in the Treatment of Impetigo

Impetigo

Norway, Sweden
Vyne Therapeutics Inc.

Completed

Study to Evaluate the Safety and Efficacy of Topical Minocycline FXFM244 in Impetigo Patients

Impetigo

Israel
IMMUNOe Research Centers
Octapharma

Unknown

A Study to Evaluate the Benefit of Octagam 5%® in Subjects With Pediatric Acute-onset Neuropsychiatric Syndrome (PANS) (PANS)

Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections | Pediatric Acute-Onset Neuropsychiatric Syndrome

United States
GlaxoSmithKline

Completed

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Hepatitis B | Tetanus | Diphtheria | Acellular Pertussis | Poliomyelitis | Streptococcus Pneumoniae Vaccines

Spain, Germany, Poland
Hospices Civils de Lyon

Unknown

The Value of 99mTc-Leukoscan® Scintigraphy in the Diagnosis of Infectious Endocarditis on Surgical Materials (PLEIM)

Endocarditis

France
Rigshospitalet, Denmark
Odense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaborators

Recruiting

Accelerated Treatment of Endocarditis (POETII)

Infectious Endocarditis

Denmark
Ole Hyldegaard
Rigshospitalet, Denmark; Herlev Hospital

Unknown

Hyperbaric Oxygen Treatment in Humans With Gram Positive Cocci Endocarditis (ENDOHOT)

Infectious Endocarditis

Denmark
University Hospital, Strasbourg, France

Unknown

Management of Infectious Endocarditis as Part of a Multidisciplinary Consensus Meeting

Endocarditis

France
Nationwide Children's Hospital

Active, not recruiting

Decreasing Antibiotic Duration for Skin and Soft Tissue Infection Using Behavioral Economics in Primary Care (SSTIBE)

Abscess | Cellulitis | Drain Abscess | Behavioral Economics | Impetigo | Skin Infection | Antibiotic Duration

United States
GlaxoSmithKline

Completed

Treatment Of Impetigo With Topical SB-275833 Ointment, 1% Versus Topical Placebo Ointment

Impetigo

India, Mexico, Netherlands, Italy, Peru
Ferrer Internacional S.A.

Completed

Efficacy and Safety of Ozenoxacin 1% Cream Versus Placebo in the Treatment of Patients With Impetigo

Impetigo

Puerto Rico
Philippine Dermatological Society
St. Luke's Medical Center

Unknown

The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial

Impetigo

Philippines
GlaxoSmithKline

Completed

EU PV for Retapamulin-Prescribing

Impetigo
NovaBay Pharmaceuticals, Inc.
Novum Pharmaceutical Research Services; International Dermatology Research,...

Completed

Safety and Efficacy of Topical NVC-422 Gel in Impetigo

Impetigo

Dominican Republic
Memorial Sloan Kettering Cancer Center

Completed

Trial of Prophylactic Versus Empirical Vancomycin for the Prevention of Streptococcal Sepsis After Hematopoietic Cell Transplantation

Hematologic Malignancies | Streptococcal Sepsis

United States
Bert Vaes

Recruiting

The Effect of AUDIT and Feedback on Pneumococcal Vaccination Coverage

Pneumococcal Infections

Belgium
GPN Vaccines

Recruiting

Safety, Tolerability and Immunogenicity of an Inactivated Whole-cell Pneumococcal Vaccine Gamma-PN3.

Pneumococcal Infections

Australia
London School of Hygiene and Tropical Medicine
Save the Children; Murdoch Children's Research Institute; Ministry of Health...

Not yet recruiting

Evaluating the Effectiveness of a Pneumococcal Immunisation Campaign in a Camp for Internally Displaced People (EEPICC)

Pneumococcal Infections

Somalia
Jena University Hospital

Completed

Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody Levels

Pneumococcal Infections

Germany
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 in Healthy Infants (V114-025) (PNEU-PED-EU-1)

Pneumococcal Infections

Australia, Belgium, Czechia, Estonia, Germany, Greece, Poland, Russian Federation, Spain
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 in Allogeneic Hematopoietic Stem Cell Transplant Recipients (V114-022/PNEU-STEM)

Pneumococcal Infections

United States, Australia, Belgium, Brazil, Canada, Colombia, France, Germany, Mexico, Sweden
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) (PNEU-PED-EU-2)

Pneumococcal Infections

Denmark, Finland, Italy, Norway, Sweden
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Interchangeability of V114 and Prevnar 13™ in Healthy Infants (V114-027/PNEU-DIRECTION)

Pneumococcal Infections

United States, Puerto Rico, Thailand, Turkey
Merck Sharp & Dohme LLC

Completed

Safety and Immunogenicity of Catch-up Vaccination Regimens of V114 (V114-024) (PNEU-PLAN)

Pneumococcal Infections

Finland, Malaysia, Poland, Russian Federation, Thailand
Merck Sharp & Dohme LLC

Completed

Evaluation of the Safety and Immunogenicity of Sequential Administration of Prevnar 13™ and Pneumovax™ 23 in Healthy Participants 50 Years of Age and Older (V110-029)

Pneumococcal Infections
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAX™23 in Healthy Adults 50 Years of Age or Older (V114-016/PNEU-PATH) (PNEU-PATH)

Pneumococcal Infections

United States, Korea, Republic of, Spain, Taiwan
Pfizer

Completed

Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Vaccine in Healthy Infants

Pneumococcal Infections

United States
SK Chemicals Co., Ltd.

Completed

Immunogenicity and Safety Study of NBP606 in Healthy Infants

Pneumococcal Infections

Korea, Republic of
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of V114 Compared to Prevnar 13™ in PPSV23-vaccinated Healthy Adults ≥65 Years of Age (V114-007)

Pneumococcal Infections
Merck Sharp & Dohme LLC

Completed

Safety, Tolerability, and Immunogenicity of Two Formulations of V114 in Healthy Adults 50 Years of Age or Older (V114-006)

Pneumococcal Infections
National Institute of Allergy and Infectious Diseases...

Completed

Pneumococcal Reference Standard

Pneumococcal Infections

United States
Johns Hopkins Bloomberg School of Public Health
Centers for Disease Control and Prevention; Institute of Child Health; Thrasher... and other collaborators

Completed

Long-term Impact of Pneumococcal Conjugate Vaccine on Carriage

Pneumococcal Infections

United States
Pfizer

Completed

Study Evaluating Safety of 13-Valent Pneumococcal Conjugate Vaccine in Healthy Elderly Subjects

Pneumococcal Infections

Sweden, United States, Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)

Pneumococcal Infections

United States, Sweden
Johns Hopkins Bloomberg School of Public Health
Wyeth is now a wholly owned subsidiary of Pfizer; United States Agency for... and other collaborators

Completed

Mother's Gift Project

Pneumococcal Infections

Bangladesh

Clinical Trials on Infections, Streptococcal

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritius

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations